Showing results (911-920 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|April 5, 2019
PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicityJames Rm Black, Robert D Goldin, Matthew Foxton, et al.Immunotherapy|September 19, 2019
Ixekizumab for treating ankylosing spondylitisSonam Kiwalkar, Secia Beier, Atul DeodharImmunotherapy|January 25, 2021
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk?Stijn J De Keukeleire, Tijl Vermassen, Zahra M Nezhad, et al.Immunotherapy|February 3, 2021
PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: the role of salvage chemo-immunotherapy combinationFrancesco Gelsomino, Francesco Facchinetti, Monia Sisi, et al.Immunotherapy|January 28, 2021
Continuation of systemic treatments and outcomes for patients with chronic graft-versus-host disease in the USAXingyue Huang, Namita Joshi, Linlin Luo, et al.Immunotherapy|January 6, 2022
Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseasesRoger H Kobayashi, Jiří Litzman, Syed Rizvi, et al.Immunotherapy|January 11, 2022
Immunoregulatory effects of dental mesenchymal stem cells on T and B lymphocyte responses in primary Sjögren's syndromeDeniz Genç, Burcu Günaydın, Serhat Sezgin, et al.Immunotherapy|August 17, 2011
Phacilitate Barcelona active immunotherapeutics forum. 11-13 May 2011, Barcelona, SpainNeal D ShoreImmunotherapy|August 17, 2011
Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growthTathagata Chakraborty, Anamika Bose, Subhasis Barik, et al.Pageof 188